Form 4: USANA Health Sciences Director Ding Xia Reports Stock Transactions

Sentiment:

SEC Form 4


Director Ding Xia of USANA Health Sciences reports the vesting and disposal of restricted stock units.

Summary

  • On May 2, 2025, Director Ding Xia of USANA Health Sciences Inc. reported transactions involving common stock and restricted stock units.
  • 674 shares of common stock were acquired through the vesting of restricted stock units.
  • 169 shares were disposed of to cover tax obligations at a price of $29.44 per share.
  • Following these transactions, Ding Xia directly owns 4,544 shares of USANA common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence for publicly traded companies. It provides transparency to investors regarding the trading activities of company leadership.

Stakeholder Impact

  • The transactions have a minimal impact on stakeholders as they represent a small portion of the overall outstanding shares.

Key Dates

DateDescription
08/02/202425% of Restricted Stock Units vest
11/02/202425% of Restricted Stock Units vest
02/02/202425% of Restricted Stock Units vest
05/02/202425% of Restricted Stock Units vest
05/02/2025Transaction Date: Vesting of restricted stock units and disposal of shares for tax obligations.
05/06/2025Date of Form 4 signature.

Keywords

USANA Health Sciences, Director, Stock Transactions, Form 4, Beneficial Ownership, Restricted Stock Units, USNA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.